Elutia (ELUT) Net Cash Flow Growth (3y) (2022 - 2026)
Powered by 
Analysis
Elutia (ELUT) Net Cash Flow Growth (3y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.79 Bn | 175.19 Bn | 7.27 Bn | -9.45% |
| 2 | Intuitive Surgical | 127.05 Bn | 121.83 Bn | 1.96 Bn | -16.59% |
| 3 | Medtronic | 117.00 Bn | 108.18 Bn | 6.34 Bn | -0.80% |
| 4 | Stryker | 103.78 Bn | 100.31 Bn | 4.50 Bn | 60.16% |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | -85.83% |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | 43.26% |
| 7 | Alcon | 32.98 Bn | 31.52 Bn | 1.68 Bn | 1.60% |
| 8 | Dexcom | 32.05 Bn | 30.10 Bn | 830.00 Mn | -26.30% |
| 9 | Steris | 20.68 Bn | 20.19 Bn | 684.20 Mn | 269.22% |
| 10 | Elutia | 36.01 Mn | 16.11 Mn | 1.45 Mn | -51.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -51.10% |
| Mar 31, 2026 | -14.77% |
| Dec 31, 2025 | 52.68% |
| Sep 30, 2025 | 23.38% |
| Jun 30, 2025 | 14.06% |
| Mar 31, 2025 | 35.70% |
| Dec 31, 2024 | -53.30% |
| Sep 30, 2024 | 49.11% |
| Jun 30, 2024 | 66.82% |
| Mar 31, 2024 | 9.36% |
| Dec 31, 2023 | -49.92% |
| Sep 30, 2023 | 105.23% |
| Jun 30, 2023 | -100.18% |
| Mar 31, 2023 | -38.34% |
| Dec 31, 2022 | 64.11% |